The Pfizer Effect: Europe’s 63,060% increase in Child Deaths following EMA approval of Covid Vaccine proves it is 100% Safe & Effective

The European Medicines Agency had finally granted emergency use approval for the use of the Pfizer COVID-19 vaccine in children aged 12 to 15.

The winds of fortune took an unexpected turn as the vaccine rollout for children commenced.

To hasten their availability, regulatory agencies like the European Medicines Agency and the U.S. Food and Drug Administration invoked emergency use authorizations, granting a temporary lifeline to these novel and dangerous vaccines.

History had already witnessed a chilling episode of ADE during the development of a dengue fever vaccine.

Sadly, in individuals who had encountered a different strain of the virus before, the vaccine seemed to amplify the risk of severe illness, a grim testament to the treacherous nature of ADE. Similar tales emerged from numerous animal studies, where potential "Vaccines" instigated lung inflammation and other adverse effects upon subsequent exposure to the virus.

The ominous specter of Vaccine-Associated Enhanced Disease loomed large during respiratory virus vaccine trials, including those against coronaviruses.

Trials for a respiratory syncytial virus vaccine illuminated a disconcerting pattern: vaccinated infants faced an increased risk of hospitalization and more severe respiratory illness upon encountering the virus.

The immune response triggered by the vaccine, rather than safeguarding against the virus, seemed to trigger an overreaction of the immune system, exacerbating the disease's symptoms.

The data, extracted from the the UK Health Security Agency Week 5,, Week 9 and Week 13 Covid-19 Vaccine Surveillance reports , painted a vivid picture of the disconcerting reality.

Click to enlarge The numbers spoke volumes, revealing that the Covid-19 vaccine recipients faced a higher risk of infection compared to the unvaccinated populace.

During week 21 of 2021, the European Medicines Agency extended the emergency use authorization of the Pfizer COVID-19 vaccine, first to children aged 12 to 15 and later to the age group of 5 to 11.

https://expose-news.com/2023/07/27/631x-increase-child-deaths-proves-covid-vaccine-is-safe/